Prilosec OTC Making Inroads Into Abbott’s Prevacid
This article was originally published in The Tan Sheet
Executive Summary
Abbott Labs plans to counter the launch of Prilosec OTC with a broad direct-to-consumer advertising campaign for its Rx proton pump inhibitor Prevacid